|
SNX18 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.986800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.528000E-01 |
| Normal-vs-Stage2 |
7.097800E-01 |
| Normal-vs-Stage3 |
2.339000E-01 |
| Normal-vs-Stage4 |
6.605000E-03 |
| Stage1-vs-Stage2 |
8.808200E-01 |
| Stage1-vs-Stage3 |
2.527700E-02 |
| Stage1-vs-Stage4 |
1.410330E-04 |
| Stage2-vs-Stage3 |
1.518220E-01 |
| Stage2-vs-Stage4 |
1.237950E-02 |
| Stage3-vs-Stage4 |
1.137350E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.572400E-01 |
| Normal-vs-AfricanAmerican |
4.537400E-01 |
| Normal-vs-Asian |
6.566800E-01 |
| Caucasian-vs-AfricanAmerican |
4.473400E-01 |
| Caucasian-vs-Asian |
6.785600E-01 |
| AfricanAmerican-vs-Asian |
3.187200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.663000E-01 |
| Normal-vs-Female |
9.247000E-01 |
| Male-vs-Female |
9.185600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.967400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.737600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.156400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.923200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.214430E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.622600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.138800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.185000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.793800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.835400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.097550E-03 |
| Classical-VS-Follicular |
1.702270E-03 |
| Classical-VS-Other |
2.643600E-01 |
| Classical-VS-Normal |
2.736000E-01 |
| Tall-VS-Follicular |
5.995000E-01 |
| Tall-VS-Other |
9.563800E-01 |
| Tall-VS-Normal |
5.155900E-02 |
| Follicular-VS-Other |
7.829000E-01 |
| Follicular-VS-Normal |
1.161400E-01 |
| Other-VS-Normal |
2.716600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.284600E-01 |
| Normal-vs-N1 |
1.332600E-01 |
| N0-vs-N1 |
4.251600E-01 |
|
|
